Incidence and Predictors of Acute Kidney Injury Among Type 2 Diabetes Mellitus Patients in Amhara Region Comprehensive Specialized Hospitals, 2021: Retrospective Follow-up Study (original) (raw)
Related papers
Epidemiology of Diabetes Mellitus: A Current Review
Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 2012
Diabetes mellitus represents worldwide an extremely important public health problem considering its high prevalence, the serious complications triggered by the disease, the associated rate of mortality and, not the least, the extremely high economic and social costs. In 1995 approximately 135 million persons were affected by diabetes and an increase of 300 million cases was estimated by the year 2025. At the end of 2012 a number of 347 million persons with diabetes was estimated, with a prediction of 552 million cases in 2030, that is 9.9% from the world's adult population. The question asked on an annual basis is: "Diabetes where do we go? Can we stop the dramatic evolution?" key words: diabetes, prevalence, mortality.
Journal of diabetes & metabolism, 2020
Objective: The aim of this study was to assess the proportion of chronic diabetic complications and factors with type-2 diabetes mellitus at Debretabor Hospital, Northwest Ethiopia, 2018. Methods: Institution based cross-sectional study was conducted among 424 systematically selected type-2 diabetes mellitus patients from March 1-April 5/2018. The collected data were entered into EPI INFO 7 and exported to SPSS version 20 for analysis. Variables with P value <0.05 considered statistically significant. Result: A total of 424 study subjects participated in the study. Overall, 222 (52.4%) (95%CI: 48-57%) of patients were diagnosed with at least one chronic complications. Patients who were >50 years of age [AOR=4.23 (95%CI: 1.80-9.89)], those taking both oral and insulin anti-diabetes mellitus medication [AOR=2.42 (95% CI: 1.18-4.94)] and patients >5 years with duration of diabetes [AOR=17.72 (95%CI: 8.25-38.07)] were positively associated, whereas patients with preventive care...
Interpreting global trends in type 2 diabetes complications and mortality
Diabetologia, 2021
International trends in traditional diabetes complications (cardiovascular, renal, peripheral vascular, ophthalmic, hepatic or neurological diseases) and mortality rates are poorly characterised. An earlier review of studies published up to 2015 demonstrated that most data come from a dozen high-income countries (HICs) in North America, Europe or the Asia–Pacific region and that, in these countries at least, rates of acute glycaemic fluctuations needing medical attention and amputations, myocardial infarction and mortality were all declining over the period. Here, we provide an updated review of published literature on trends in type 2 diabetes complications and mortality in adults since 2015. We also discuss issues related to data collection, analysis and reporting that have influenced global trends in type 2 diabetes and its complications. We found that most data on trends in type 2 diabetes, its complications and mortality come from a small number of HICs with comprehensive surve...
The Growing Epidemic of Diabetes Mellitus
Current Vascular Pharmacology, 2020
Background: During the past decades, the prevalence of diabetes (DM) has increased significantly, mainly as a result of continuous rise in the incidence of type 2 DM. According to World Health Organization statistics, >422 million adults globally were suffering from DM in 2014 and a continuous rise in DM prevalence is expected. Objective: The present review considers recent epidemiological data providing worldwide estimates regarding the incidence of DM. Methods: A comprehensive literature search was conducted to identify available data from epidemiological studies evaluating the current burden of DM. Results: Over the past few decades the prevalence of DM has risen significantly in nearly all countries and may be considered as a growing epidemic. Urbanization and income status are major factors which influence current rates in the prevalence studies introducing interesting differences between several population groups. Conclusion: Having recognized the global burden of DM, we no...
The rising tide of type 2 diabetes
The British Journal of Diabetes & Vascular Disease, 2001
The number of people with diabetes is now considered to have reached epidemic proportions. Globally more the 150 million people have diabetes, accounting for more than 2% of the world's population and 3—5% of adults in most westernised societies. The incidence rates of type 1 and particularly type 2 diabetes are increasing in all societies and on all continents. Type 2 diabetes accounts for more than 95% of all diabetes. Type 2 diabetes is highly prevalent in the elderly and is now emerging in childhood. In developed countries diabetes and its complications constitute the fourth or fifth leading cause of death, and type 2 diabetes reduces remaining lifespan by 5—10 years. Diabetes (all types) is estimated to affect about 2.4 million people (prevalence of 4%) in the UK, of whom 1.4 million (prevalence of 2.5%) are diagnosed and one million undiagnosed. With the global prevalence of diabetes predicted to exceed 220 million by 2010 and 300 million by 2025 there is a major internati...
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2020
Background Diabetes mellitus (DM) is a group of metabolic disorders characterized by hyperglycemia resulting from impairment in insulin secretion, insulin action, or both. It is responsible for a wide range of acute and chronic complications. In this study, we aimed to assess acute complications of diabetes and its predictors among adult DM patients at Jimma Medical Center (JMC), southwest Ethiopia. Methods A facility-based cross-sectional study involving 348 diabetic patients was conducted from February to May 31, 2019 at JMC. Logistic regression was conducted to identify predictors of acute complications of diabetes. Variables with P≤0.25 on bivariate logistic regression were considered candidates for multivariate regression. ORs and 95% CIs with P<0.05 were considered statistically significant. Results Of the 348 patients, 225 (64.7%) were male, and the mean age of study participants was 46±15.5 years. Most (281, 80.7%) had type 2 DM. More than two-thirds (240, 69%)had diabete...
Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019
Frontiers in Endocrinology, 2021
BackgroundChronic kidney disease (CKD) is a public health problem largely caused by diabetes. The epidemiology of diabetes mellitus–related CKD (CKD-DM) could provide specific support to lessen global, regional, and national CKD burden.MethodsData were derived from the GBD 2019 study, including four measures and age-standardized rates (ASRs). Estimated annual percentage changes and 95% CIs were calculated to evaluate the variation trend of ASRs.ResultsDiabetes caused the majority of new cases and patients with CKD in all regions. All ASRs for type 2 diabetes–related CKD increased over 30 years. Asia and Middle socio-demographic index (SDI) quintile always carried the heaviest burden of CKD-DM. Diabetes type 2 became the second leading cause of CKD and CKD-related death and the third leading cause of CKD-related DALYs in 2019. Type 2 diabetes–related CKD accounted for most of the CKD-DM disease burden. There were 2.62 million incident cases, 134.58 million patients, 405.99 thousand d...